Suspension Stocks List

Suspension Stocks Recent News

Date Stock Title
Nov 19 PII POLARIS FACTORY RACING'S BROCK HEGER TRIUMPHS, CAPTURING FIRST SCORE BAJA 1000 VICTORY AND SECURING 2024 SCORE UTV PRO OPEN CLASS SERIES CHAMPIONSHIP
Nov 18 PII Polaris Partners with Call of Duty®, Introduces RZR Pro R 4 in Season 01 of Call of Duty Warzone®
Nov 18 SNY FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria
Nov 18 LEG Is Leggett & Platt, Incorporated (LEG) the Best Nickel Stock to Invest in?
Nov 18 PII Will Polaris (PII) Bounce Back?
Nov 15 SNY How analysts are reacting to RFK Jr. as Trump's HHS pick
Nov 15 SNY FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
Nov 15 SNY Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of.
Nov 15 SNY Stocks to Watch Friday: Applied Materials, Alibaba, Domino's, Novo Nordisk
Nov 15 SNY Trump’s RFK Jr. Pick Weighs on Vaccine Makers
Nov 15 SNY Regeneron, Sanofi say resubmitted application to expand Dupixent label accepted in U.S.
Nov 15 SNY European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department
Nov 15 SNY EMA’s CHMP recommends Sanofi’s Sarclisa approval for multiple myeloma
Nov 15 SNY Drugmaker stocks slide as Trump picks vaccine sceptic RFK Jr for US health job
Nov 15 SNY Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria
Nov 15 SNY Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)
Nov 15 SNY Viking Fund Management Sells Big Oil Stocks In Q3, Cuts Tesla Position In Half, Adds To Largest Position Broadcom
Nov 14 SNY Vaccine makers close lower amid reports RFK Jr may head HHS (update)
Nov 14 SNY Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myeloma
Nov 14 EYPT EyePoint Pharmaceuticals: Low Price And Good Data Create An Opportunity
Suspension

Browse All Tags